Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > IL-23A

IL-23A

Brief Information

Name:Interleukin-23
Target Synonym:Interleukin-23
Number of Launched Drugs:8
Number of Drugs in Clinical Trials:12
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
ILA-H525h Human Human IL-23A Protein, Fc Tag
ILA-H525h-structure
ILA-H525h-sds
ACRO Quality

Part of Bioactivity data

ILA-H525h-ELISA
 IL-23A ELISA

Immobilized Human IL-23A Protein, Fc Tag (Cat. No. ILA-H525h) at 1 μg/mL (100 μL/well) can bind Mirikizumab with a linear range of 0.002-0.25 μg/mL (QC tested).

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Ustekinumab C-340; CNTO-1275 Approved Johnson & Johnson Innovative Medicine Stelara, 喜达诺 United States Plaque psoriasis Janssen Biotech Inc 2009-09-25 Multiple Sclerosis; Plaque psoriasis; Dermatitis, Atopic; Crohn Disease; Hidradenitis Suppurativa; Common Variable Immunodeficiency; Uveitis; Colitis, Ulcerative; Arthritis, Psoriatic; Takayasu Arteritis; Lupus Erythematosus, Systemic; Psoriasis; Diabetes Mellitus, Type 1; Arthritis, Juvenile; Sjogren's Syndrome; Spondylitis, Ankylosing; Pouchitis; Ichthyosis; Dermatomyositis; Inflammatory Bowel Diseases; Type I Leukocyte Adhesion Defect; Polymyositis; Liver Cirrhosis, Biliary Details
Ustekinumab biosimilar(Formycon) FYB-202 Approved Formycon AG OTULFI EU Crohn Disease; Colitis, Ulcerative Fresenius Kabi Deutschland Gmbh, Formycon AG 2024-09-25 Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease Details
Ustekinumab Biosimilar (qyuns) QX-001S; QX-001-S; HDM-3001 Approved Qyuns Therapeutics Co Ltd Mainland China Plaque psoriasis Qyuns Therapeutics Co Ltd 2024-10-29 Psoriasis; Plaque psoriasis Details
Ustekinumab Biosimilar(Celltrion) CT-P43 Approved Celltrion Inc Steqeyma, Steqeyma IV Canada Plaque psoriasis; Arthritis, Psoriatic; Crohn Disease Celltrion Inc 2024-08-01 Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease Details
Ustekinumab biosimilar (Biocon) Approved Biocon Biologics Ltd Bmab 1200, Yesintek United States Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease Biocon Biologics Inc 2024-11-29 Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis Details
Ustekinumab biosimilar (Alvotech) AVT04; AVT-04 Approved Alvotech hf Jamteki, Uzpruvo, SELARSDI™, JamtekiTM, Ustekinumab BS (F) Japan Arthritis, Psoriatic; Psoriasis Fuji Pharma Co Ltd 2023-09-25 Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease Details
Ustekinumab biosimilar(Amgen) ABP-654 Approved Amgen Inc Wezlana, WEZLANA, wezenla United States Crohn Disease; Colitis, Ulcerative; Arthritis, Psoriatic; Plaque psoriasis Amgen Inc 2023-10-31 Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis Details
Ustekinumab biosimilar(DM Bio) DA-3115; DMB-3115 Approved Dong-A Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd IMULDOSA, Absimky United States Psoriasis Dong-A ST Co Ltd, Meiji Seika Kaisha Ltd 2024-10-11 Psoriasis; Colitis, Ulcerative; Crohn Disease Details
Ustekinumab C-340; CNTO-1275 Approved Johnson & Johnson Innovative Medicine Stelara, 喜达诺 United States Plaque psoriasis Janssen Biotech Inc 2009-09-25 Multiple Sclerosis; Plaque psoriasis; Dermatitis, Atopic; Crohn Disease; Hidradenitis Suppurativa; Common Variable Immunodeficiency; Uveitis; Colitis, Ulcerative; Arthritis, Psoriatic; Takayasu Arteritis; Lupus Erythematosus, Systemic; Psoriasis; Diabetes Mellitus, Type 1; Arthritis, Juvenile; Sjogren's Syndrome; Spondylitis, Ankylosing; Pouchitis; Ichthyosis; Dermatomyositis; Inflammatory Bowel Diseases; Type I Leukocyte Adhesion Defect; Polymyositis; Liver Cirrhosis, Biliary Details
Ustekinumab biosimilar(Formycon) FYB-202 Approved Formycon AG OTULFI EU Crohn Disease; Colitis, Ulcerative Fresenius Kabi Deutschland Gmbh, Formycon AG 2024-09-25 Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease Details
Ustekinumab Biosimilar (qyuns) QX-001S; QX-001-S; HDM-3001 Approved Qyuns Therapeutics Co Ltd Mainland China Plaque psoriasis Qyuns Therapeutics Co Ltd 2024-10-29 Psoriasis; Plaque psoriasis Details
Ustekinumab Biosimilar(Celltrion) CT-P43 Approved Celltrion Inc Steqeyma, Steqeyma IV Canada Plaque psoriasis; Arthritis, Psoriatic; Crohn Disease Celltrion Inc 2024-08-01 Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease Details
Ustekinumab biosimilar (Biocon) Approved Biocon Biologics Ltd Bmab 1200, Yesintek United States Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease Biocon Biologics Inc 2024-11-29 Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis Details
Ustekinumab biosimilar (Alvotech) AVT04; AVT-04 Approved Alvotech hf Jamteki, Uzpruvo, SELARSDI™, JamtekiTM, Ustekinumab BS (F) Japan Arthritis, Psoriatic; Psoriasis Fuji Pharma Co Ltd 2023-09-25 Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Plaque psoriasis; Crohn Disease Details
Ustekinumab biosimilar(Amgen) ABP-654 Approved Amgen Inc Wezlana, WEZLANA, wezenla United States Crohn Disease; Colitis, Ulcerative; Arthritis, Psoriatic; Plaque psoriasis Amgen Inc 2023-10-31 Psoriasis; Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Plaque psoriasis Details
Ustekinumab biosimilar(DM Bio) DA-3115; DMB-3115 Approved Dong-A Pharmaceutical Co Ltd, Meiji Seika Pharma Co Ltd IMULDOSA, Absimky United States Psoriasis Dong-A ST Co Ltd, Meiji Seika Kaisha Ltd 2024-10-11 Psoriasis; Colitis, Ulcerative; Crohn Disease Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Brazikumab AMG-139; MEDI-2070; Anti-IL-23-MAb (Amgen) Phase 2 Clinical Amgen Inc Inflammatory Bowel Diseases; Psoriasis; Colitis, Ulcerative; Crohn Disease Details
mRNA-2752 mRNA-2752 Phase 1 Clinical Moderna Inc, Astrazeneca Plc Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Carcinoma, Transitional Cell; Triple Negative Breast Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma; Melanoma; Carcinoma, Non-Small-Cell Lung Details
SFA-002 SFA-002; SFA002 Phase 1 Clinical Arthritis, Rheumatoid; Plaque psoriasis Details
IL-23/CGRP bispecific antibody (Lilly) Phase 1 Clinical Eli Lilly And Company Autoimmune Diseases Details
Ustekinumab biosimilar (Curateq Biologics) BP38; BP-38 Phase 1 Clinical CuraTeQ Biologics Pvt Ltd Psoriasis Details
Ustekinumab Biosimilar (NeuClone/Serum Institute of India) Phase 1 Clinical Neuclone, Serum Institute Of India Ltd Autoimmune Diseases Details
Ustekinumab biosimilar(Rani Therapeutics) RT-111 Phase 1 Clinical Rani Therapeutics Llc Psoriasis Details
SOR-102 SOR-102 Phase 1 Clinical Sorriso Pharmaceuticals Inc Inflammatory Bowel Diseases; Colitis, Ulcerative Details
Kagocel Clinical Nearmedic Plus Llc Respiratory Tract Infections; Respirovirus Infections; Influenza, Human Details
Ustekinumab biosimilar (BioFactura) BFI-751 BioFactura Australia Pty Ltd Details
Brazikumab AMG-139; MEDI-2070; Anti-IL-23-MAb (Amgen) Phase 2 Clinical Amgen Inc Inflammatory Bowel Diseases; Psoriasis; Colitis, Ulcerative; Crohn Disease Details
mRNA-2752 mRNA-2752 Phase 1 Clinical Moderna Inc, Astrazeneca Plc Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Carcinoma, Transitional Cell; Triple Negative Breast Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma; Melanoma; Carcinoma, Non-Small-Cell Lung Details
SFA-002 SFA-002; SFA002 Phase 1 Clinical Arthritis, Rheumatoid; Plaque psoriasis Details
IL-23/CGRP bispecific antibody (Lilly) Phase 1 Clinical Eli Lilly And Company Autoimmune Diseases Details
Ustekinumab biosimilar (Curateq Biologics) BP38; BP-38 Phase 1 Clinical CuraTeQ Biologics Pvt Ltd Psoriasis Details
Ustekinumab Biosimilar (NeuClone/Serum Institute of India) Phase 1 Clinical Neuclone, Serum Institute Of India Ltd Autoimmune Diseases Details
Ustekinumab biosimilar(Rani Therapeutics) RT-111 Phase 1 Clinical Rani Therapeutics Llc Psoriasis Details
SOR-102 SOR-102 Phase 1 Clinical Sorriso Pharmaceuticals Inc Inflammatory Bowel Diseases; Colitis, Ulcerative Details
Kagocel Clinical Nearmedic Plus Llc Respiratory Tract Infections; Respirovirus Infections; Influenza, Human Details
Ustekinumab biosimilar (BioFactura) BFI-751 BioFactura Australia Pty Ltd Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message